PRECISION BIOSCIENCES INC Gain (Loss) on Disposition of Assets
PRECISION BIOSCIENCES INC (DTIL) reported Gain (Loss) on Disposition of Assets of $1.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-08-06
- PRECISION BIOSCIENCES INC gain (loss) on disposition of assets for the quarter ending 2026-06-30 was $1.00K.
- PRECISION BIOSCIENCES INC gain (loss) on disposition of assets for the quarter ending 2026-03-31 was $4.00K.
- PRECISION BIOSCIENCES INC gain (loss) on disposition of assets for the quarter ending 2025-12-31 was -$390.00K.
- PRECISION BIOSCIENCES INC gain (loss) on disposition of assets for the quarter ending 2025-09-30 was $3.00K.
- PRECISION BIOSCIENCES INC gain (loss) on disposition of assets for fiscal 2025 was -$421.00K.
- PRECISION BIOSCIENCES INC gain (loss) on disposition of assets for fiscal 2024 was -$436.00K.
- PRECISION BIOSCIENCES INC gain (loss) on disposition of assets for fiscal 2023 was -$461.00K.
- PRECISION BIOSCIENCES INC gain (loss) on disposition of assets for fiscal 2022 was -$30.00K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month | Gain (Loss) on Disposition of Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $1.00K 10-Q · filed 2026-08-06 | $5.00K 10-Q · filed 2026-08-06 | -$385.00K derived: sum of 3 quarters · filed 2026-08-06 | -$382.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $4.00K 10-Q · filed 2026-05-05 | -$386.00K derived: sum of 2 quarters · filed 2026-05-05 | -$383.00K derived: sum of 3 quarters · filed 2026-05-05 | -$408.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | -$390.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$387.00K derived: sum of 2 quarters · filed 2026-03-12 | -$412.00K derived: sum of 3 quarters · filed 2026-08-06 | -$421.00K 10-K · filed 2026-03-12 | |
| 2025-09-30 | $3.00K 10-Q · filed 2025-11-03 | -$22.00K derived: sum of 2 quarters · filed 2026-08-06 | -$31.00K 10-Q · filed 2025-11-03 | -$213.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$25.00K 10-Q · filed 2026-08-06 | -$34.00K 10-Q · filed 2026-08-06 | -$216.00K derived: sum of 3 quarters · filed 2026-08-06 | -$216.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | -$9.00K 10-Q · filed 2026-05-05 | -$191.00K derived: sum of 2 quarters · filed 2026-05-05 | -$191.00K derived: sum of 3 quarters · filed 2026-05-05 | -$380.00K derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | -$182.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$182.00K derived: sum of 2 quarters · filed 2026-03-12 | -$371.00K derived: sum of 3 quarters · filed 2026-03-12 | -$436.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-03 | -$189.00K derived: sum of 2 quarters · filed 2025-11-03 | -$254.00K 10-Q · filed 2025-11-03 | -$778.00K derived: sum of 4 quarters · filed 2025-11-03 | |
| 2024-06-30 | -$189.00K 10-Q · filed 2025-08-07 | -$254.00K 10-Q · filed 2025-08-07 | -$778.00K derived: sum of 3 quarters · filed 2025-08-07 | -$780.00K derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | -$65.00K 10-Q · filed 2025-05-15 | -$589.00K derived: sum of 2 quarters · filed 2025-05-15 | -$591.00K derived: sum of 3 quarters · filed 2025-05-15 | -$519.00K derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | -$524.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$526.00K derived: sum of 2 quarters · filed 2025-03-26 | -$454.00K derived: sum of 3 quarters · filed 2025-03-26 | -$461.00K 10-K · filed 2025-03-26 | |
| 2023-09-30 | -$2.00K 10-Q · filed 2024-11-04 | $70.00K derived: sum of 2 quarters · filed 2024-11-04 | $63.00K 10-Q · filed 2024-11-04 | $44.00K derived: sum of 4 quarters · filed 2024-11-04 | |
| 2023-06-30 | $72.00K 10-Q · filed 2024-08-01 | $65.00K 10-Q · filed 2024-08-01 | $46.00K derived: sum of 3 quarters · filed 2024-08-01 | $93.00K derived: sum of 4 quarters · filed 2024-08-01 | |
| 2023-03-31 | -$7.00K 10-Q · filed 2024-05-13 | -$26.00K derived: sum of 2 quarters · filed 2024-05-13 | $21.00K derived: sum of 3 quarters · filed 2024-05-13 | -$26.00K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | -$19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $28.00K derived: sum of 2 quarters · filed 2024-03-27 | -$19.00K derived: sum of 3 quarters · filed 2024-03-27 | -$30.00K 10-K · filed 2024-03-27 | -$106.00K 10-K · filed 2023-03-09 |
| 2022-09-30 | $47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | -$11.00K 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | -$47.00K 10-Q · filed 2023-08-04 | -$58.00K 10-Q · filed 2023-08-04 | |||
| 2022-03-31 | -$11.00K 10-Q · filed 2023-05-09 | ||||
| 2021-12-31 | -$26.00K 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |